HIF1A and Sepsis: Our study provides further evidence that vascular repair and the resolution of inflammatory lung injury is driven by HIF-1α and FoxM1 in ECs and that pharmacological activation of the HIF-1α/FoxM1 signaling axis is a putative therapeutic strategy for severe sepsis and ARDS.